HungaroTrial

Executive Summary

HungaroTrial is a Hungarian clinical research organization (CRO) founded in 2005, headquartered in Budapest, that provides comprehensive clinical trial management and regulatory services to pharmaceutical and biotechnology companies. Leveraging its deep expertise in the Central and Eastern European (CEE) region, the company offers cost-effective and efficient trial execution, capitalizing on the region's diverse patient populations and favorable regulatory environment. As a service provider, HungaroTrial does not develop its own drugs but facilitates trials for clients, positioning itself as a strategic partner for global drug development. The CRO market in CEE is growing due to increasing outsourcing trends and the region's competitive advantages, which bodes well for HungaroTrial's continued expansion.

Upcoming Catalysts (preview)

• Q3 2026Expansion of service offerings into new therapeutic areas70% success
• TBDStrategic partnership with a major pharmaceutical company for regional trials50% success
• TBDRegulatory harmonization in CEE attracting more clinical trials to the region80% success